These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25420513)

  • 1. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
    Inoue H; Emori K; Toyonaga A; Oho K; Kumamoto M; Haruta T; Mitsuyama K; Tsuruta O; Sata M
    Kurume Med J; 2014; 61(1-2):1-8. PubMed ID: 25420513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome.
    Kumamoto M; Toyonaga A; Inoue H; Miyakoda K; Morita Y; Emori K; Sakamoto Y; Oho K; Sata M
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1129-35. PubMed ID: 20594229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.
    Miyamoto Y; Oho K; Kumamoto M; Toyonaga A; Sata M
    J Gastroenterol Hepatol; 2003 Aug; 18(8):934-42. PubMed ID: 12859723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of improved liver function after balloon-occluded retrograde transvenous obliteration: relation to hepatic vein pressure gradient.
    Uehara H; Akahoshi T; Tomikawa M; Kinjo N; Hashimoto N; Nagao Y; Kamori M; Maehara Y
    J Gastroenterol Hepatol; 2012 Jan; 27(1):137-41. PubMed ID: 21722180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis.
    Kato T; Uematsu T; Nishigaki Y; Sugihara J; Tomita E; Moriwaki H
    Intern Med; 2001 Aug; 40(8):688-91. PubMed ID: 11518103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience.
    Akahoshi T; Hashizume M; Tomikawa M; Kawanaka H; Yamaguchi S; Konishi K; Kinjo N; Maehara Y
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1702-9. PubMed ID: 18713295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) performed in a patient with primary biliary cirrhosis with severe recurrent hepatic encephalopathy due to splenorenal shunt.
    Takashimizu S; Watanabe N; Kojima S; Kagawa T; Mine T; Myojin K; Koizumi J
    Tokai J Exp Clin Med; 2007 Jul; 32(2):70-4. PubMed ID: 21319062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for portosystemic shunts.
    Waguri N; Hayashi M; Yokoo T; Sato R; Arao Y; Setsu T; Sato M; Kohisa J; Hama I; Ohsugi K; Aiba T; Yoneyama O; Furukawa K; Sugimura K; Igarashi K; Suda T
    J Vasc Interv Radiol; 2012 May; 23(5):650-7. PubMed ID: 22459878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion.
    Ishikawa T; Sasaki R; Nishimura T; Matsuda T; Maeda M; Iwamoto T; Saeki I; Hidaka I; Takami T; Sakaida I
    J Gastroenterol Hepatol; 2019 Jan; 34(1):215-223. PubMed ID: 30070412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of solitary gastric fundal varices and portosystemic encephalopathy accompanying liver cirrhosis by balloon-occluded retrograde transvenous obliteration (B-RTO): a case report.
    Ohmoto K; Miyake I; Tsuduki M; Ohno S; Yamamoto S
    Hepatogastroenterology; 1999; 46(26):1249-52. PubMed ID: 10370701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy.
    Fukuda T; Hirota S; Sugimura K
    J Vasc Interv Radiol; 2001 Mar; 12(3):327-36. PubMed ID: 11287510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience.
    Mukund A; Rajesh S; Arora A; Patidar Y; Jain D; Sarin SK
    J Vasc Interv Radiol; 2012 Sep; 23(9):1200-6. PubMed ID: 22832139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful control of portal hypertension-related complications after two embolization procedures for multiple and large spontaneous portosystemic shunts in a patient with liver cirrhosis.
    Ueno W; Sato N; Miura K; Morimoto N; Watanabe S; Nomoto H; Isoda N; Kijima S; Kikuchi T; Manaka S; Mori H; Yamamoto H
    Clin J Gastroenterol; 2021 Aug; 14(4):1227-1232. PubMed ID: 33993428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal hemodynamics and clinical outcomes of patients with gastric varices after balloon-occluded retrograde transvenous obliteration.
    Kasuga A; Mizumoto H; Matsutani S; Kobayashi A; Endo T; Ando T; Yukisawa S; Maruyama H; Yokosuka O
    J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):898-903. PubMed ID: 20461439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients.
    Ninoi T; Nishida N; Kaminou T; Sakai Y; Kitayama T; Hamuro M; Yamada R; Nakamura K; Arakawa T; Inoue Y
    AJR Am J Roentgenol; 2005 Apr; 184(4):1340-6. PubMed ID: 15788621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of balloon-occluded retrograde transvenous obliteration for gastric varices concurrent with hepatocellular carcinoma.
    Matsuoka S; Tamura A; Ishii T; Miyazawa S; Mizutani T; Ito K; Kamimura S; Matsumoto N; Nakamura H; Nirei K; Matsumura H; Yamagami H; Moriyama M; Takayama T
    Hepatogastroenterology; 2014; 61(136):2301-4. PubMed ID: 25699370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balloon-occluded retrograde transvenous obliteration of varices: focusing on the portal hemodynamics and the recent techniques.
    Hirota S; Kobayashi K; Kako Y; Takaki H; Yamakado K
    Hepatol Int; 2018 Feb; 12(Suppl 1):102-111. PubMed ID: 28875380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrograde Transvenous Obliteration (RTO): A New Treatment Option for Hepatic Encephalopathy.
    Lee EW; Lee AE; Saab S; Kee ST
    Dig Dis Sci; 2020 Sep; 65(9):2483-2491. PubMed ID: 32002756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Balloon-occluded retrograde transvenous obliteration (B-RTO) for portal hypertension].
    Hirota S; Fukuda T; Matsumoto S; Sugimoto K; Isaki K; Yoshikawa T; Akasaka Y; Sugimura K
    Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Jun; 60(7):361-7. PubMed ID: 10921294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.